Peter Fernandes - Chief Executive Officer, Principal Financial and Accounting Officer at Bellerophon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Principal Financial and Accounting Officer
Stock Symbol
BLPH
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter Fernandes since 10/17/2024

Holdings reported by Peter Fernandes for Bellerophon Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to Buy) 100K $152K $1.52 Jun 7, 2023 Direct Common Stock
Common Stock 22.5K $2.34K $0.10 Dec 9, 2022 Direct
Restricted Stock Units 32.5K Dec 9, 2022 Direct Common Stock

Transactions reported by Peter Fernandes for Bellerophon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.